Document Type : Letter to the Editor


1 Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Functional Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran




  1. Vignatelli L, Zenesini C, Belotti LMB, Baldin E, Bonavina G, Calandra-Buonaura G, et al. Risk of hospitalization and death for COVID-19 in people with Parkinson's disease or parkinsonism. Mov Disord 2021; 36(1): 1-10.
  2. Lo RY. Epidemiology of atypical parkinsonian syndromes. Tzu Chi Med J 2022; 34(2): 169-81.
  3. Jecmenica-Lukic M, Petrovic IN, Pekmezovic T, Kostic VS. Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: A prospective natural history study. J Neurol 2014; 261(8): 1575-83.
  4. Salari M, Zali A, Ashrafi F, Etemadifar M, Sharma S, Hajizadeh N, et al. Incidence of anxiety in Parkinson's disease during the coronavirus disease (COVID-19) pandemic. Mov Disord 2020; 35(7): 1095-6.
  5. Fasano A, Antonini A, Katzenschlager R, Krack P, Odin P, Evans AH, et al. Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: The COVID-19 experience. Mov Disord Clin Pract 2020; 7(4): 361-72.
  6. Moscovich M, Boschetti G, Moro A, Teive HAG, Hassan A, Munhoz RP. Death certificate data and causes of death in patients with parkinsonism. Parkinsonism Relat Disord 2017; 41: 99-103.
  7. Backstrom D, Granasen G, Domellof ME, Linder J, Jakobson MS, Riklund K, et al. Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology 2018; 91(22): e2045-e2056.